Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Feb-24 8:18 PM View:  | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 06-Feb-24 | Option Sale | 1,590 | $1.69 | $2,687.10 | (7%) 22.41K to 20.82K | |
| 06-Feb-24 8:18 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 05-Feb-24 | Option Exercise | 3,750 | -- | -- | 20% 18.66K to 22.41K | |
| 06-Feb-24 8:20 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 05-Feb-24 | Option Exercise | 10,375 | -- | -- | 10% 106.17K to 116.55K | |
| 06-Feb-24 8:15 PM View: | Krueger Nancy General Counsel | Atyr Pharma Inc (LIFE) | 05-Feb-24 | Option Exercise | 2,688 | -- | -- | 22% 12.08K to 14.77K | |
| 12-Dec-23 6:50 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 12-Dec-23 | Purchase | 12,000 | $1.18 | $14,136.00 | 13% 94.17K to 106.17K | |
| 12-Dec-23 6:50 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 11-Dec-23 | Private Purchase | 3,000 | $1.17 | $3,510.00 | 3% 91.17K to 94.17K | |
| 13-Nov-23 4:11 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 13-Nov-23 | Purchase | 13,578 | $1.11 | $15,085.20 | 17% 77.59K to 91.17K | |
| 13-Nov-23 4:11 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 10-Nov-23 | Private Purchase | 1,422 | $1.14 | $1,618.24 | 2% 76.17K to 77.59K | |
| 01-Aug-23 4:07 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 28-Jul-23 | Private Purchase | 15,000 | $2.01 | $30,223.50 | 25% 61.17K to 76.17K | |
| 19-May-23 4:27 PM View: | Coughlin Timothy P Director | Atyr Pharma Inc (LIFE) | 17-May-23 | Gift | 6,000 | -- | -- | 100% 6.0K to 12.0K | |
| 19-May-23 4:27 PM View: | Coughlin Timothy P Director | Atyr Pharma Inc (LIFE) | 17-May-23 | Gift | 6,000 | -- | -- | (50%) 12.0K to 6.0K | |
| 11-May-23 9:00 AM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 10-May-23 | Private Purchase | 200,000 | $2.25 | $450,000.00 | 25% 801.06K to 1.0M | |
| 28-Apr-23 4:56 PM View: | Zaknoen Sara Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 28-Apr-23 4:52 PM View: | Gross Jane A Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 28-Apr-23 4:53 PM View: | Lucas Svetlana Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 28-Apr-23 10:00 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 43% 13.8K to 19.8K | |
| 28-Apr-23 4:54 PM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | < 1% 795.06K to 801.06K | |
| 28-Apr-23 4:51 PM View: | Coughlin Timothy P Director | Atyr Pharma Inc (LIFE) | 26-Apr-23 | Option Exercise | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 06-Feb-23 7:00 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 06-Feb-23 | Option Sale | 1,566 | $2.36 | $3,695.76 | (9%) 17.03K to 15.46K | |
| 06-Feb-23 6:57 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 03-Feb-23 | Option Exercise | 10,375 | -- | -- | 20% 50.8K to 61.17K | |
| 06-Feb-23 7:03 PM View: | Krueger Nancy General Counsel | Atyr Pharma Inc (LIFE) | 03-Feb-23 | Option Exercise | 2,688 | -- | -- | 61% 4.39K to 7.08K | |
| 06-Feb-23 7:00 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 03-Feb-23 | Option Exercise | 3,750 | -- | -- | 28% 13.28K to 17.03K | |
| 21-Nov-22 9:04 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 21-Nov-22 | Private Purchase | 10,000 | $2.14 | $21,405.00 | 25% 40.8K to 50.8K | |
| 06-Jul-22 5:02 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 01-Jul-22 | Private Purchase | 15,000 | $2.88 | $43,164.00 | 58% 25.8K to 40.8K | |
| 18-Jan-22 8:39 AM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 13-Jan-22 | Private Purchase | 1,923 | $6.75 | $12,980.20 | 19% 10.19K to 12.11K | |
| 10-Jan-22 8:03 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 07-Jan-22 | Private Purchase | 5,000 | $6.76 | $33,806.50 | 24% 20.8K to 25.8K | |
| 15-Nov-21 6:56 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 15-Nov-21 | Market Purchase | 2,500 | $8.57 | $21,437.50 | 14% 18.3K to 20.8K | 2% |
| 22-Sep-21 10:00 PM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Private Purchase | 250,000 | $8.00 | $2,000,000.00 | 31% 795.06K to 1.05M | |
| 22-Sep-21 10:00 PM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Gift | 250,000 | -- | -- | 46% 545.06K to 795.06K | |
| 22-Sep-21 10:00 PM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 20-Sep-21 | Gift | 250,000 | -- | -- | (24%) 1.05M to 795.06K | |
| 25-May-21 9:05 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 21-May-21 | Market Sale | 2,500 | $4.34 | $10,850.00 | (2%) 118.08K to 115.58K | 4% |
| 20-May-21 8:52 AM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 18-May-21 | Market Purchase | 10,000 | $4.01 | $40,100.00 | 121% 8.3K to 18.3K | |
| 20-May-21 8:55 AM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 18-May-21 | Market Purchase | 50,000 | $3.98 | $199,000.00 | 10% 495.06K to 545.06K | |
| 09-Feb-21 9:15 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 09-Feb-21 | Market Option Sale | 390 | $7.66 | $2,987.40 | (4%) 10.22K to 9.83K | |
| 09-Feb-21 9:12 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 09-Feb-21 | Market Option Sale | 778 | $7.66 | $5,959.48 | (9%) 9.08K to 8.3K | |
| 09-Feb-21 9:15 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 06-Feb-21 | Option Exercise | 892 | -- | -- | 10% 9.33K to 10.22K | |
| 09-Feb-21 9:12 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 06-Feb-21 | Option Exercise | 1,785 | -- | -- | 24% 7.29K to 9.08K | |
| 03-Sep-20 9:47 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 02-Sep-20 | Market Sale | 7,260 | $4.01 | $29,112.60 | (6%) 125.33K to 118.08K | (6%) |
| 03-Sep-20 9:47 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 28-Aug-20 | Market Sale | 100 | $4.00 | $400.00 | (< 1%) 125.44K to 125.33K | (6%) |
| 28-Aug-20 9:09 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 27-Aug-20 | Market Sale | 5,440 | $4.09 | $22,249.60 | (4%) 130.88K to 125.44K | (4%) |
| 28-Aug-20 9:09 PM View: | Clarke John K Director | Atyr Pharma Inc (LIFE) | 26-Aug-20 | Market Sale | 2,200 | $4.30 | $9,451.20 | (2%) 133.07K to 130.88K | 1% |
| 23-Jun-20 4:23 PM View: | Shukla Sanjay President and CEO Director | Atyr Pharma Inc (LIFE) | 19-Jun-20 | Market Purchase | 6,000 | $4.27 | $25,620.00 | 465% 1.29K to 7.29K | (< 1%) |
| 23-Jun-20 4:27 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 19-Jun-20 | Market Purchase | 1,850 | $4.22 | $7,807.00 | 25% 7.3K to 9.15K | < 1% |
| 28-May-20 8:26 PM View: | Krueger Nancy General Counsel | Atyr Pharma Inc (LIFE) | 20-May-20 | Market Option Sale (Planned) | 322 | $3.62 | $1,165.64 | (11%) 3.06K to 2.73K | (17%) |
| 22-May-20 8:13 PM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 20-May-20 | Market Sale | 8,447 | $3.64 | $30,738.60 | (2%) 503.5K to 495.06K | (17%) |
| 28-May-20 8:26 PM View: | Krueger Nancy General Counsel | Atyr Pharma Inc (LIFE) | 16-May-20 | Option Exercise | 892 | -- | -- | 41% 2.17K to 3.06K | |
| 11-Feb-20 11:58 AM View: | Schimmel Paul Director | Atyr Pharma Inc (LIFE) | 10-Feb-20 | Market Purchase | 254,000 | $4.25 | $1,079,500.00 | 102% 249.5K to 503.5K | (< 1%) |
| 07-Feb-20 7:30 PM View: | Church Jill Marie Chief Financial Officer | Atyr Pharma Inc (LIFE) | 07-Feb-20 | Market Option Sale | 375 | $4.03 | $1,511.25 | (5%) 7.5K to 7.13K | (5%) |
| 07-Feb-20 7:37 PM View: | Shukla Sanjay President and CEO | Atyr Pharma Inc (LIFE) | 07-Feb-20 | Market Option Sale | 745 | $4.03 | $3,002.35 | (37%) 2.04K to 1.29K | (5%) |
| 07-Feb-20 7:37 PM View: | Shukla Sanjay President and CEO | Atyr Pharma Inc (LIFE) | 06-Feb-20 | Option Exercise | 1,786 | -- | -- | 714% 0.25K to 2.04K |
